The Influence of Earnings Management on Pharmaceutical Company Stock Prices

Authors

  • Stefanie Valencia Kezia Kalengkian Universitas Klabat
  • Sheren Laura Lasaru Universitas Klabat
  • I Gusti Agung Musa Budidarma Universitas Klabat

DOI:

https://doi.org/10.55927/ministal.v2i1.2577

Keywords:

Earnings Management, Stock Price, Pharmaceutical Companies

Abstract

This research was conducted to determine and analyze the effect of earnings management on the stock prices of pharmaceutical companies in Indonesia. In this study, earnings management is the independent variable and stock prices are the dependent variable. The sample used is a pharmaceutical company listed on the Indonesia Stock Exchange. The sampling method was carried out using purposive sampling. Detection of earnings management behavior in this study was measured using the modified Jones model. The data analysis technique uses the classical assumption test, namely the multicollinearity test and the heteroscedasticity test by testing the hypothesis using multiple linear regression. The results of this study indicate that pharmaceutical companies actually practice earnings management by reducing profits as seen from the average negative discretionary accruals (DA). According to the results of the study, earnings management has no effect on the stock prices of pharmaceutical companies listed on the IDX. This means that there are other factors that will further influence the movement of pharmaceutical company stock prices in Indonesia in 2017-2021.

Downloads

Download data is not yet available.

References

Anthony, R. N., & Govindarajan, V. (2007). Management Control System. New Delhi: Mc Graw Hill India.

Baker, T., Collins, D., & Reitenga, A. (2003). Stock option compensation and earnings management incentives. Journal of Accounting, Auditing & Finance, 18(4), 557-582.

Dechow, P. M., Sloan, R. G., & Sweeney, A. P. (1995). Detecting Earnings Management. The Accounting Review, 193-225.

Mishkin, F. S. (2016). The Economics of Money, Banking, and Financial Markets. Columbia: Pearson.

Oktaviani, H. D. (2016). Pengaruh ukuran dewan direksi, proporsi dewan, komisaris independen, dan ukuran komite audit terhadap praktik manajemen laba pada perusahaan farmasi yang terdaftar di BEI Tahun 2009–2014. Jurnal Akuntansi UNESA, 4(2), 1-24.

Putriana, M., Artati, S., & Utami, V. J. (2018). Pengaruh Corporate Social Responsibility Terhadap Manajemen Laba Dengan Leverage Dan Growth Sebagai Variabel Control Pada Industri Farmasi Yang Terdaftar Di Bursa Efek Indonesia. JMAS (Jurnal Manajemen Dan Sains), 3(2), 226-236.

Robinson, T. R., Greuning, H. V., Henry, E., Broihahn, M. A., & Tweedie, D. (2008). International Financial Statement Analysis. Canada: Wiley.

Rohmaniyah, A., & Khanifah, K. (2018). Analisis Manajemen Laba pada Laporan Keuangan Perbankan Syariah. Jurnal Ekonomi dan Bisnis, 9-15.

Setianingse, U. (2020). Pengaruh Earning Per Share, Quick Ratio, Kurs Terhadap Harga Saham Pada Perusahaan Farmasi Yang Terdaftar Di Bursa Efek Indonesia (BEI). Jurnal Ilmu dan Riset Manajemen.

Shuli, I. (2011). Earnings management and the quality of the financial reporting. Perspectives of Innovations, Economics, and Business, 8(2), 45-48.

Sulistyanto, H. S. (2018). Manajemen Laba: Teoi dan Model Empiris. Jakarta: PT Grasindo Jakarta.

Usman. (2013, November 7). Earnings Management Dalam Kaitannya Dengan Laporan Keuangan. Retrieved from Ung Repository: https://repository.ung.ac.id/hasilriset/show/1/297/earnings-management-dalamkaitannya-dengan-laporan-keuangan.html

Utami, S. S. (2008). Investasi Di Pasar Modal Berdasarkan Laporan Keuangan Dan Harga Saham. Jurnal Akuntansi dan Sistem Teknologi Informasi.

Downloads

Published

2023-01-31

How to Cite

Stefanie Valencia Kezia Kalengkian, Sheren Laura Lasaru, & I Gusti Agung Musa Budidarma. (2023). The Influence of Earnings Management on Pharmaceutical Company Stock Prices. Jurnal Ekonomi Dan Bisnis Digital, 2(1), 259–268. https://doi.org/10.55927/ministal.v2i1.2577